Charles R. Harrison

Oncology

100 Michigan St NE
Grand Rapids, MI 49503

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Journal: Gynecologic oncology

Published: August 31, 2012

Showing 1-1 of 1

Last Updated: 09/26/2026